sunesis [sunesis.jpg]
 
AMENDMENT TO THE AMENDED AND
RESTATED CONSULTING AGREEMENT

THIS AMENDMENT (“Amendment”) effective December 21, 2005 (“Amendment Effective
Date”) is to the existing amended and restated Consulting Agreement (the
“Agreement”) dated August 8, 2005 (the “Effective Date’) between James A. Wells,
Ph.D. (“Consultant”) and Sunesis Pharmaceuticals Inc. (“Sunesis”). All
capitalized terms herein shall have the same meaning as set forth in the
Agreement.

WHEREAS, the parties hereto desire to modify the existing Agreement to provide
the terms and conditions upon which Consultant may continue to provide
consulting services to Sunesis.

THEREFORE, in consideration of the promises and mutual covenants contained in
this Amendment, the parties hereby agree to the terms and conditions set forth
below.

1.
Section 2 of the Agreement is deleted in its entirety and replaced with the
following section:

“2.
Compensation.

A.  Cash. As consideration for Consultant’s performance of Services, Sunesis
shall make cash payments to ‘The Regents of the University of California’ on
behalf of Consultant as set forth below.

i)  For SAB Responsibilities: Consultant shall receive $1,500 per day for
participation at each SAB Meeting.

ii)  For Consulting Responsibilities: Consultant shall be paid $5,000 for two
(2) days of consulting per month (approx. ½ day per week per month). Additional
consulting days will be paid at a rate of $3,000 per day (assuming an eight (8)
hour day). Sunesis will make payments for Services performed under this
paragraph 2.A.ii) on a monthly basis thirty (30) days after Sunesis’ receipt of
Consultant’s invoice.

B. Stock Options. Separately, any Incentive Stock Options (ISOs) granted by
Sunesis to Consultant while he was an employee will be converted to
Non-Qualified Stock Options (NQSOs), and all unvested stock options will
continue to vest during the next twelve (12) months in accordance with the
normal vesting schedule for each grant. At the end of the 12- month period
following the Effective Date vesting will end.”

 
1

--------------------------------------------------------------------------------

 
 
sunesis [sunesis.jpg]
 
Except as otherwise stated in this Amendment, all other terms and conditions of
the original Agreement shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment to be executed as
of the Amendment Effective Date.  
  

Sunesis Pharmaceuticals, Inc.     Consultant 341 Oyster Point Boulevard     1341
Columbus Avenue South San Francisco, California 94080     Burlingame, California
94010

 

        By:     By:

--------------------------------------------------------------------------------

Daryl B. Winter, Ph.D.
Senior Vice President, General
Counsel
   

--------------------------------------------------------------------------------

James A. Wells, Ph.D.
    Date Signed:     Date Signed:

--------------------------------------------------------------------------------

   

--------------------------------------------------------------------------------

 

 
 
2

--------------------------------------------------------------------------------